Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
Overall Status
Terminated
CT.gov ID
NCT00001178
Collaborator
(none)
597
1
382.9
1.6

Study Details

Study Description

Brief Summary

The Cognitive Neuroscience Section of the National Institute of Neurological Disorders and Stroke proposes to continue its cross-sectional and longitudinal studies of cerebral metabolism in frontal lobe dementias and atypical basal ganglia disorders. These studies include repeated assessments of neuropsychological and brain anatomical and metabolic function in subjects with these important and possibly related brain disorders.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Objective

    To continue the cross-sectional and longitudinal studies performed by the Cognitive Neuroscience Section of NINDS on the neuroanatomy, cerebral metabolism, neuropsychology, and genetics of frontotemporal dementia, corticobasal syndrome, and related brain disorders.

    Study population

    Frontal lobe dementias and atypical basal ganglia disorders including frontotemporal dementia, corticobasal syndrome, and related brain disorders.

    Design

    A cross-sectional assessment of neuropsychological, brain anatomical and metabolic function, and genetic measures in subjects with these disorders.

    Outcome measures

    MRI, FDG-PET, neuropsychological and clinical tests, genetics, and neuropathology.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    597 participants
    Official Title:
    Regional Cerebral Utilization of Glucose in Patients With a Diagnosis of Frontal Lobe Dementia, Atypical Parkinsonian Disorder, and Other Basal Ganglia Disorders
    Study Start Date :
    Jan 19, 1981
    Study Completion Date :
    Dec 17, 2012

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      • Subjects will be recruited from the NIH referral center, neurological and psychiatric clinics, from self or family referral in response to advertisements or from private physicians. Healthy volunteers will include subjects who are considered at-risk for the development of FTD or CBS and subjects who serve as normal controls matched for key characteristics with the patients.
      INCLUSION CRITERIA FOR PATIENTS:
      • Diagnosis of possible / probable FTD or CBS

      • Caregiver willing and able to accept the responsibilities involved in the study

      EXCLUSION CRITERIA:
      • Pregnant women. Women of childbearing potential will be screened by history for the possibility of pregnancy and undergo a urine pregnancy test. These women will be excluded from the imaging portions of the protocol.

      • Behavioral symptoms that would preclude the gathering of data for the study

      • Other medical or social condition that would preclude participation in the opinion of the investigators

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda Maryland United States 20892

      Sponsors and Collaborators

      • National Institute of Neurological Disorders and Stroke (NINDS)

      Investigators

      • Principal Investigator: Eric M Wassermann, M.D., National Institute of Neurological Disorders and Stroke (NINDS)

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00001178
      Other Study ID Numbers:
      • 810010
      • 81-N-0010
      First Posted:
      Nov 4, 1999
      Last Update Posted:
      Dec 12, 2019
      Last Verified:
      Dec 17, 2012

      Study Results

      No Results Posted as of Dec 12, 2019